Good read (below) of the Chief Scientific Officer who is along with Dr Mikaelian working tirelessly to keep this moving forward .. the fda and DR both added things they required and QNTA is complying .. these things take time .. however in the meantime, I take comfort in reading about those who are doing the work …
Khalid Matalka, Ph.D., SI(ASCP) Chief Scientific Officer https://www.linkedin.com/in/khalid-matalka A committed, creative, professional immunobiologist with 30+ years of experience in scientific research, medical writing, strategies, bioanalysis, drug discovery and development, laboratory settings and education
Scientific Expertise:? Developing, designing and executing immunology/immuno-oncology/cancer therapy/ pharmacology in vivo, ex vivo and in vitro models, and toxicity/safety studies ? Developing and validating broad range of bioanalytical assays (ELISA, ELISPOT, MSD, cell-based assays, cytokine/chemokine expression assays, PCR, flow cytometry) ? Preclinical and clinical sample testing ? Immunogenicity, PK & PD studies, and biomarker analysis
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.